CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


04-February-2014
Cerilliant introduces a 100 µg/mL solution of the anticonvulsant internal standard Carbamazepine-10,11-epoxide-13C6.

Carbamazepine-10,11-epoxide- C-128
100 µg/mL in Methanol

This stable-labeled internal standard is suitable for use in quantitation of carbamazepine levels or isotope dilution methods by GC/MS or LC/MS for applications in pain prescription monitoring, clinical toxicology, therapeutic drug monitoring or urine drug testing. Carbamazepine-10,11-epoxide is the primary active metabolite of carbamazepine, an anticonvulsant and moodstabilizing drug used primarily in the treatment of epilepsy and neuropathic pain.

Cerilliant will soon introduce Certified Spiking Solutions® of the following anticonvulsant internal standards:
 
10,11-Dihydro-10-Hydroxycarbamazepine-13C6 (D-104)
Oxcarbazepine-13C(O-039)
Gabapentin-13C3 (G-018) 



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn